loadpatents
Patent applications and USPTO patent grants for FITCH; Duke M..The latest application filed is for "prolyl hydroxylase inhibitors".
Patent | Date |
---|---|
Prolyl Hydroxylase Inhibitors App 20210347740 - Duffy; Kevin J. ;   et al. | 2021-11-11 |
Crystalline forms Grant 11001556 - | 2021-05-11 |
Heterocyclic amides useful as protein modulators Grant 10981901 - | 2021-04-20 |
Substituted pyridines as inhibitors of DNMT1 Grant 10975056 - | 2021-04-13 |
Substituted fused pyrazole compounds and their use as LRRK2 inhibitors Grant 10975081 - | 2021-04-13 |
Pyrazole derivatives as bromodomain inhibitors Grant 10966961 - | 2021-04-06 |
Inhibitors of human immunodeficiency virus replication Grant 10954252 - | 2021-03-23 |
Pyridyl derivatives as bromodomain inhibitors Grant 10934272 - | 2021-03-02 |
Pyridinone dicarboxamide for use as bromodomain inhibitors Grant 10927080 - | 2021-02-23 |
Modulators of indoleamine 2,3-dioxygenase Grant 10927078 - | 2021-02-23 |
Modulators of indoleamine 2,3-dioxygenase Grant 10906924 - | 2021-02-02 |
Modulators of indoleamine 2,3-dioxygenase Grant 10899754 - | 2021-01-26 |
Biopharmaceutical compositions comprising interleukin-5 antibody Grant 10870695 - | 2020-12-22 |
Compounds Grant 10858367 - | 2020-12-08 |
Pyridyl derivatives as bromodomain inhibitors Grant 10849897 - | 2020-12-01 |
Pyridine dicarboxamide derivatives as bromodomain inhibitors Grant 10844015 - | 2020-11-24 |
Modulators of indoleamine 2,3-dioxygenase Grant 10787442 - | 2020-09-29 |
Benzimidazole derivatives as PI3 kinase inhibitors Grant 10660898 - | 2020-05-26 |
Prolyl Hydroxylase Inhibitors App 20200157055 - DUFFY; Kevin J. ;   et al. | 2020-05-21 |
Antituberculosis agent Grant 10624893 - | 2020-04-21 |
Enhancer of zeste homolog 2 inhibitors Grant 10604531 - | 2020-03-31 |
Heterocyclic amides as kinase inhibitors Grant 10590085 - | 2020-03-17 |
Benzo[b]furans as bromodomain inhibitors Grant 10583112 - | 2020-03-10 |
Low concentration antibody formulations Grant 10537638 - | 2020-01-21 |
Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseases Grant 10513517 - | 2019-12-24 |
Naphthyridines as integrin antagonists Grant 10487080 - | 2019-11-26 |
Enhancer of Zeste Homolog 2 inhibitors Grant 10478426 - | 2019-11-19 |
2-OXO-1,2-dihydropyridine-3,5-dicarboxamide compounds as bromodomain inhibitors Grant 10471050 - | 2019-11-12 |
Benzimidazole derivatives as bromodomain inhibitors Grant 10442786 - | 2019-10-15 |
Pyridinone dicarboxamide for use as bromodomain inhibitors Grant 10428026 - | 2019-10-01 |
Pyridinone dicarboxamide for use as bromodomain inhibitors Grant 10370356 - | 2019-08-06 |
Compounds αβintegrin antagonists Grant 10342783 - | 2019-07-09 |
Antigen binding proteins Grant 10344088 - | 2019-07-09 |
Prolyl hydroxylase inhibitors Grant 10,336,711 - Fitch , et al. | 2019-07-02 |
D-proline derivatives as SAP depleting agent Grant 10328052 - | 2019-06-25 |
Anti-LAG-3 binding proteins Grant 10280221 - | 2019-05-07 |
Prolyl Hydroxylase Inhibitors App 20180305323 - Fitch; Duke M. ;   et al. | 2018-10-25 |
Prolyl hydroxylase inhibitors Grant 10,035,779 - Fitch , et al. July 31, 2 | 2018-07-31 |
Prolyl Hydroxylase Inhibitors App 20160297772 - FITCH; Duke M. ;   et al. | 2016-10-13 |
Prolyl Hydroxylase Inhibitors App 20150315157 - Fitch; Duke M. ;   et al. | 2015-11-05 |
Prolyl Hydroxylase Inhibitors App 20140336383 - Fitch; Duke M. ;   et al. | 2014-11-13 |
Prolyl hydroxylase inhibitors Grant 8,815,884 - Fitch , et al. August 26, 2 | 2014-08-26 |
Prolyl Hydroxylase Inhibitors App 20140024666 - Fitch; Duke M. ;   et al. | 2014-01-23 |
Prolyl hydroxylase inhibitors Grant 8,557,834 - Fitch , et al. October 15, 2 | 2013-10-15 |
Prolyl Hydroxylase Inhibitors App 20130072487 - Duffy; Kevin J. ;   et al. | 2013-03-21 |
Prolyl hydroxylase inhibitors Grant 8,324,208 - Duffy , et al. December 4, 2 | 2012-12-04 |
Substituted 1,8-naphthyridinecarboxamides for use as prolyl hydroxylase inhibitors Grant 7,897,612 - Fitch , et al. March 1, 2 | 2011-03-01 |
Prolyl Hydroxylase Inhibitors App 20110039895 - Chai; Deping ;   et al. | 2011-02-17 |
Prolyl Hydroxylase Inhibitors App 20100305133 - Colon; Mariela ;   et al. | 2010-12-02 |
Prolyl Hydroxylase Inhibitors App 20100305154 - Fitch; Duke M. | 2010-12-02 |
(5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiaz- Ol-4(5h)-one App 20100286041 - DUFFY; Kevin J. ;   et al. | 2010-11-11 |
Prolyl Hydroxylase Inhibitors App 20100113444 - Duffy; Kevin J. ;   et al. | 2010-05-06 |
5(Z)-5-(6-quinoxalinylmethylidene)-2-[2,6-dichlorophenyl)amino]-1,3-thiazo- l-4(5H)-one Grant 7,674,792 - Duffy , et al. March 9, 2 | 2010-03-09 |
Novel Chemical Compounds App 20090203692 - Duffy; Kevin ;   et al. | 2009-08-13 |
Prolyl Hydroxylase Inhibitors App 20090176825 - Fitch; Duke M. ;   et al. | 2009-07-09 |
Prolyl Hydroxylase Inhibitors App 20090082357 - Fitch; Duke M. ;   et al. | 2009-03-26 |
Novel Chemical Compounds App 20080261974 - Duffy; Kevin J ;   et al. | 2008-10-23 |
Novel Chemical Compounds App 20080262027 - Duffy; Kevin J. ;   et al. | 2008-10-23 |
Novel Chemical Compounds App 20080214455 - Duffy; Kevin ;   et al. | 2008-09-04 |
Compounds, Compositions, and Methods App 20080176830 - Adams; Nicholas D. ;   et al. | 2008-07-24 |
Novel Chemical Compounds App 20070249599 - Duffy; Kevin J. ;   et al. | 2007-10-25 |
Prolyl Hydroxylase Inhibitors App 20070213335 - FITCH; Duke M. ;   et al. | 2007-09-13 |
5(Z)-5-(6-Quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiaz- ol-4(5H)-one App 20070179144 - Duffy; Kevin J. ;   et al. | 2007-08-02 |
Novel anti-infectives App 20040147739 - Chai, Deping ;   et al. | 2004-07-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.